| Listed site | cro | cro |
|---|
| Summary | Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995. | Global preclinical CRO specializing in kinase drug discovery, cell-based assays, in vivo pharmacology, and immuno-oncology with 1,000+ cell lines and hundreds of validated protein targets across US and EU facilities. |
|---|
| Services | - Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Specialized & Large-Animal Models
- Bioanalysis
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Clinical Imaging Core Lab
- Oncology Specialty Services
- Immunology & Inflammation Services
- Virology Services
- GLP Toxicology
- Safety Pharmacology
- Translational Research
- Preclinical In Vitro Studies
- Regulatory Affairs
- LC-MS Bioanalysis (Small Molecule)
- High-Throughput Screening
- Genetic Toxicology
- Computational & In-Silico Drug Discovery
- Carcinogenicity Studies
- DART (Reproductive & Developmental Toxicology)
- Flow Cytometry Services
- Analytical Method Development & Validation
- ICH Stability Studies
- Ligand-Binding Bioanalysis (Large Molecule)
| - High-Throughput Screening
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- GLP Toxicology
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Preclinical In Vitro Studies
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Discovery Research
- Specialized & Large-Animal Models
- Oncology Specialty Services
- Immunology & Inflammation Services
- Target Identification & Validation
- Genetic Toxicology
- Immunogenicity Assays (ADA / NAb)
|
|---|
| Modalities | - Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Radiopharmaceutical
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
|
|---|
| Indications | - Oncology
- Immunology
- Infectious Disease
- Dermatology
- Gastroenterology
- Nephrology
- Metabolic
- Rare Disease
- Respiratory
| - Oncology
- Immunology
- Infectious Disease
|
|---|
| Locations | - Headquarters, Dijon, Bourgogne-Franche-Comté, France
- Headquarters
| - Global Headquarters, Malvern, PA, USA
- Hershey, Hershey, PA, USA
- Freiburg, Freiburg, Freiburg, Germany
- Heidelberg, Heidelberg, Heidelberg, Germany
- Research Facility, Hershey, PA, USA
- Research Facility, Freiburg, Freiburg, Germany
- Research Facility, Heidelberg, Heidelberg, Germany
|
|---|
| Certifications | Data not yet provided. | - ISO · Identifier: ISO 9001:2015
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|